Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Small Cell Lung Carcinoma 19Ovarian Neoplasms 18Neuroblastoma 15Fallopian Tube Neoplasms 14Neoplasms 6Carcinoma, Ovarian Epithelial 6Ganglioneuroblastoma 5Neoplasm Metastasis 4Lung Neoplasms 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Recurrence 3Glioma 3Central Nervous System Neoplasms 3Sarcoma, Ewing 2Rhabdoid Tumor 2Retinoblastoma 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1SCLC, Extensive Stage 1SCLC 1Rhabdomyosarcoma 1Retinal Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pleuropulmonary blastoma 1

Interventions

pembrolizumab 34Cisplatin 28Brachytherapy 16Paclitaxel 15Carboplatin 15Bevacizumab 15Radiotherapy 14Blood Specimen Collection 13Specimen Handling 12Magnetic Resonance Spectroscopy 11Colposcopy 11Nivolumab 10Drug Therapy 9atezolizumab 8Human Papillomavirus DNA Tests 8Gemcitabine 8lenvatinib 7Radiation 6Platinum 6Biopsy 6toripalimab 5cemiplimab 5Surveys and Questionnaires 5Standard of Care 5Radiotherapy, Intensity-Modulated 5Practice Guidelines as Topic 5Patient Navigation 5Methods 5Fulvestrant 5Fluorodeoxyglucose F18 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Topotecan × 1 year × Clear all
NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
686 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07418749 2026-04-06

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Recruiting
398 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04697628 2026-02-24

innovaTV 301

Seagen Inc.

Phase 3 Completed
502 enrolled 18 charts 1 FDA
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡